Article info
Prevention
Randomised controlled trial
Radiofrequency ablation of Barrett's oesophagus with confirmed low-grade dysplasia reduces risk of development of high-grade dysplasia and adenocarcinoma
- Correspondence to : Dr Christine PJ Caygill, UK National Barrett's Oesophagus Registry, Royal Free Campus, University College London, London NW32PF, UK; c.caygill{at}ucl.ac.uk
Citation
Radiofrequency ablation of Barrett's oesophagus with confirmed low-grade dysplasia reduces risk of development of high-grade dysplasia and adenocarcinoma
Publication history
- First published July 9, 2014.
Online issue publication
August 16, 2023
Article Versions
- Previous version (16 August 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions